Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5642 Journals
4485 Congresses
10100+ Unique Records

Expert Review of Anticancer Therapy


Title Abbreviation
Expert Rev Anticancer Ther
ISSN
1473-7140
Electronic ISSN
1744-8328
Readership
Biomedical Researchers, Clinical Pharmacists, Clinical Pharmacologists, Clinicians, Hematologists, Immunologists, Nuclear Medicine Physicians, Nurse Oncologists, Oncologists, Radiation Oncologists, Scientists
Scope
Expert Review of Anticancer Therapy [ISSN 1473-7140]; [e-ISSN 1744-8328] is a MEDLINE-indexed, international journal publishing comprehensive peer-reviewed content on the major issues in clinical oncology. Coverage in the journal is focused on, but not limited to, the following key areas: Anticancer agents; Novel therapies in development; Cancer management; Biomarkers; Diagnostics; Clinical trials; Treatment guidelines. The journal welcomes clinically focused original research, reviews, editorials and drug profile articles.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
Taylor & Francis, Inc. - UK
To see more details about Expert Review of Anticancer Therapy, Subscribe Now!
Impact Factor JCR Categories/Rank Circulation Electronic Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
 
– Kait G
Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
– Michael K.
Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
- Weill Cornell Medical Library